PHILLIP KEEHAN: Open Payments
NPI 1568146736 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$979 in 41 payments from 13 companies in 2025. Trend: 2023 $868 · 2024 $1,401 · 2025 $979
Food & beverage: $979
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $152 |
| AKEBIA THERAPEUTICS INC | 2 | $151 |
| Amgen Inc. | 8 | $134 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $112 |
| Alexion Pharmaceuticals, Inc. | 4 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| KYOWA KIRIN, INC. | 2 | $50 |
| Lilly USA, LLC | 2 | $49 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
Products named: Vafseo, FARXIGA, Kerendia, JARDIANCE, KRYSTEXXA, ULTOMIRIS, CRYSVITA, JYNARQUE.
Industry payments across NY — which companies pay providers there.
